173 related articles for article (PubMed ID: 29030084)
1. Characterization and use of the novel human multiple myeloma cell line MC-B11/14 to study biological consequences of CRISPR-mediated loss of immunoglobulin A heavy chain.
Walters DK; Arendt BK; Tschumper RC; Wu X; Jelinek DF
Exp Hematol; 2018 Jan; 57():42-49.e1. PubMed ID: 29030084
[TBL] [Abstract][Full Text] [Related]
2. Analysis of clonal relationship using single-cell polymerase chain reaction in a patient with concomitant mantle cell lymphoma and multiple myeloma.
Yamaguchi M; Ohno T; Miyata E; Toyoda H; Nishii K; Masuya M; Kita K; Shiku H
Int J Hematol; 2001 Apr; 73(3):383-5. PubMed ID: 11345207
[TBL] [Abstract][Full Text] [Related]
3. A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation.
Yufu Y; Goto T; Choi I; Uike N; Kozuru M; Ohshima K; Taniguchi T; Motokura T; Yatabe Y; Nakamura S
Cancer; 1999 Apr; 85(8):1750-7. PubMed ID: 10223569
[TBL] [Abstract][Full Text] [Related]
4. Double-hit myeloma with IGH/MYC and IGH/CCND1 translocations.
Ji M; Jang S; Lee JH; Seo EJ
Ann Hematol; 2013 Aug; 92(8):1129-31. PubMed ID: 23307601
[No Abstract] [Full Text] [Related]
5. Rearrangement of a VH-associated LINE-1 element with the expressed IgH cluster in a murine myeloma cell line.
Bard JA; Birshtein BK
J Immunol; 1995 Jan; 154(1):201-8. PubMed ID: 7995940
[TBL] [Abstract][Full Text] [Related]
6. Acute promyelocytic leukaemia complicating multiple myeloma: evidence of different cell lineages.
Dunkley S; Gibson J; Iland H; Li C; Joshua D
Leuk Lymphoma; 1999 Nov; 35(5-6):623-6. PubMed ID: 10609802
[TBL] [Abstract][Full Text] [Related]
7. 14q32 chromosomal translocations: a hallmark of plasma cell dyscrasias?
Avet-Loiseau H; Minvielle S; Mellerin MP; Magrangeas F; Bataille R
Hematol J; 2000; 1(5):292-4. PubMed ID: 11920205
[No Abstract] [Full Text] [Related]
8. The t(11;14) (q13;q32) in multiple myeloma cell line KMS12 has its 11q13 breakpoint 330 kb centromeric from the cyclin D1 gene.
Vaandrager JW; Kluin P; Schuuring E
Blood; 1997 Jan; 89(1):349-50. PubMed ID: 8978314
[No Abstract] [Full Text] [Related]
9. Establishment and characterization of a new human myeloma cell line, KYdelta-1, producing the delta/kappa type immunoglobulin.
Ueda C; Yamada H; Akasaka T; Ohmori K; Sasada M; Uchiyama T; Ohno H
Cancer Genet Cytogenet; 2001 Oct; 130(1):42-50. PubMed ID: 11672773
[TBL] [Abstract][Full Text] [Related]
10. The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant.
Chang H; Sloan S; Li D; Zhuang L; Yi QL; Chen CI; Reece D; Chun K; Keith Stewart A
Br J Haematol; 2004 Apr; 125(1):64-8. PubMed ID: 15015970
[TBL] [Abstract][Full Text] [Related]
11. Near-tetraploidy clone can evolve from a hyperdiploidy clone and cause resistance to lenalidomide and bortezomib in a multiple myeloma patient.
Yuan J; Shah R; Kulharya A; Ustun C
Leuk Res; 2010 Jul; 34(7):954-7. PubMed ID: 20138360
[TBL] [Abstract][Full Text] [Related]
12. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of a new human Bence Jones-type myeloma cell line, NOP-2.
Nagai T; Ogura M; Morishita Y; Okumura M; Kato Y; Morishima Y; Hirabayashi N; Ohno R; Saito H
Int J Hematol; 1991 Apr; 54(2):141-9. PubMed ID: 1747447
[TBL] [Abstract][Full Text] [Related]
14. Impact of t(11;14) as a sole and concomitant abnormality on outcomes in multiple myeloma.
Bal S; Giri S; Godby KN; Costa LJ
Br J Haematol; 2021 Oct; 195(1):e113-e116. PubMed ID: 34165783
[No Abstract] [Full Text] [Related]
15. Nonsecretion of myeloma protein in spite of an increase in tumor burden by chemotherapy.
Kubota K; Kurabayashi H; Kawada E; Okamoto K; Tamura J; Shirakura T
Ann Hematol; 1991 Oct; 63(4):232-3. PubMed ID: 1932306
[TBL] [Abstract][Full Text] [Related]
16. Clonally related IgA- and IgE-secreting plasma cells in a myeloma patient.
Bakkus MH; Schots R; Gomez La Fuente PB; Van Riet I; Thielemans K; De Waele M; Van Camp B
Eur J Haematol; 2000 Nov; 65(5):348-55. PubMed ID: 11092467
[TBL] [Abstract][Full Text] [Related]
17. New patterns of relapse in multiple myeloma: a case of "light chain escape" in which FLC predicted relapse earlier than urine and serum immunofixation.
Caldini A; Nozzoli C; Terreni A; Staderini M; Berardi M; Biagioli T; Brogi M; Bosi A
Clin Chem Lab Med; 2016 Jun; 54(6):991-5. PubMed ID: 26581069
[TBL] [Abstract][Full Text] [Related]
18. A translocation t(2;14)(p11.2;q32) involving rearrangements of immunoglobulin heavy chain and kappa light chain genes in B-cell lymphoma.
Subramaniyam S; Geyer JT; Liu YC; Mathew S
Leuk Lymphoma; 2015; 56(10):2992-4. PubMed ID: 25682965
[No Abstract] [Full Text] [Related]
19. Heterogeneous breakpoints on the immunoglobulin genes are involved in fusion with the 5' region of BCL2 in B-cell tumors.
Yonetani N; Ueda C; Akasaka T; Nishikori M; Uchiyama T; Ohno H
Jpn J Cancer Res; 2001 Sep; 92(9):933-40. PubMed ID: 11572760
[TBL] [Abstract][Full Text] [Related]
20. Multiple myeloma: new evidence and insights from the immunoglobulin heavy chain gene and phenotypes.
Takishita M; Kosaka M
Leuk Lymphoma; 1995 Nov; 19(5-6):395-400. PubMed ID: 8590838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
